2011 Fiscal Year Final Research Report
Drug discovery of utilizing of characteristics of angiotensin II type 1 receptor blockers
| Project/Area Number |
21591065
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Kidney internal medicine
|
|---|
| Research Institution | Fukuoka University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SAKU Keijiro 福岡大学, 医学部, 教授 (40183371)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Keywords | ドラックエフェクト / クラスエフェクト / イノシトールリン酸産生能 / 細胞外シグナル調節キナーゼ活性 |
|---|
| Research Abstract |
We analyzed the drug(molecular or differential) effects of angiotensin II type 1(AT1) receptor blockers. We found that candesartan has strong blocking effect of cell signaling after wash-out. In addition, irbesartan has a strong anti-inflammation and valsatan showed a highly selective behavior for AT1 receptor. Before designing a new ARB, we identified the olmesartan, olmesartan-related compound R239470 and R794847, which induced inverse agonism, antagonism and agonism, respectively.
|
Research Products
(20 results)
